RCS - Intnl. Biotechnology - Latest Factsheet and Blog

International Biotechnology Trust

31/10/2024 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241031:nRSe4512Ka&default-theme=true

RNS Number : 4512K  Intl. Biotechnology Trust PLC  31 October 2024

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

 

IBT's factsheet for the month ended 30 September 2024 is now available
directly via its web page. Please click here
(https://www.schroders.com/en-gb/uk/individual/funds-and-strategies/investment-trusts/international-biotechnology-trust/)
, then 'latest factsheet'.

 

Healthcare has been a huge subject of debate in previous US elections,
contributing to significant market volatility, but the topic is more muted
this time. Clearly, it's important to understand how different outcomes may
impact the biotech sector. In their latest blog post, Portfolio Managers Ailsa
Craig and Marek Poszepczynski take a look at what to expect, with help from
the history books….

 

The blog can be read here:
https://www.schroders.com/en-gb/uk/individual/content/how-will-the-us-election-impact-biotechnology-/
(https://www.schroders.com/en-gb/uk/individual/content/how-will-the-us-election-impact-biotechnology-/)

 

To sign up for IBT updates by email, please click here
(https://www.schroders.com/en-gb/uk/individual/never-miss-an-update/) .

 

 

ENDS

 

 

Enquiries:

 

 Schroder Investment Management Limited

 Charlotte Banks (Press)                                                     020 7658 6000

 Kirsty Preston

 Kerry Higgins (Company Secretary)                                           020 7658 6000

 Kaso Legg Communications (Financial PR)

 Charles Gorman                                                              IBT@kl-communications.com (mailto:IBT@kl-communications.com)

 Henry Taylor

 Effie Aye Maung Hider

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRALFLFXZBLXFBQ